MedTrace Logo

The Presence and Role of Zygomatic-temporal Neuroma Triggering Cluster Headache

NCT04845451 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2022-11-30

No results posted yet for this study

Summary

Role of a neuroma of zygomatic-temporal in triggering of a cluster headache. Exploratory diagnosis, resection, and pathological examination of tumor anticipated

.

Conditions

  • Cluster Headache
  • Craniofacial Pain Syndrome

Interventions

OTHER

Minimal surgical exploration for a neuroma

Orientation marking of the trigger point by injectable sterile methylene blue dye 0.1ml. Marking a 2-3-centimeter long incision line 7 mm from the Neuroma marking on the skin. Local anesthesia using plain 2% lidocaine infiltration of the circumferential exploratory area. Sterile prep and drape in surgical fashion. Meticulous exploratory preparation of the subcutaneous tissue 20 mm at each side of the incision line. Appropriate visibility of the ZT nerve branches embedded in lipomatous and connective tissue over the temporal fascia. Exploratory visualization of the subcutaneous marked tissue by methylene blue using a binocular magnification eases visualization. Using an Adson tissue forceps with side grasping teeth, now an exploratory touch of the above and distal of the marking would deliver the hypersensitive painful Neuroma tissue for sharp excision using surgical scissors. Control of bleeding and skin closure. Sterile pressure dressing. Specimen be sent to pathologic examination.

Sponsors & Collaborators

  • Ohsi, Steven, M.D

    collaborator UNKNOWN

  • Radfar, Amir, M.D

    collaborator UNKNOWN

  • FARO T. OWIESY, M.D

    lead OTHER

Principal Investigators

  • Faro T Owiesy, M.D. · CORONA DOCTORS MEDICAL CLINICS

  • Steven Ohsie, M.D · Affiliated Patholgy

  • Amir Radfar, M.D,MPH · Corona doctors medical clinics

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-09
Primary Completion
2022-09-30
Completion
2022-10-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04845451 on ClinicalTrials.gov